Terms: = Lung cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS
217 results:
1. Evolutionary trajectories of small cell lung cancer under therapy.
George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
[TBL] [Abstract] [Full Text] [Related]
2. Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts.
Zhang L; Wang Y; Wang L; Wang M; Li S; He J; Ji J; Li K; Cao L
J Mol Med (Berl); 2024 Jan; 102(1):69-79. PubMed ID: 37978056
[TBL] [Abstract] [Full Text] [Related]
3. I-cbp112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs.
Strachowska M; Gronkowska K; Sobczak M; Grodzicka M; Michlewska S; Kołacz K; Sarkar T; Korszun J; Ionov M; Robaszkiewicz A
Biomed Pharmacother; 2023 Dec; 168():115798. PubMed ID: 37913733
[TBL] [Abstract] [Full Text] [Related]
4. NOTCH1 and crebbp co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study.
Ikeda S; Tsuboi M; Sakai K; Misumi T; Akamatsu H; Shoda H; Sakakura N; Nakamura A; Ohde Y; Hayashi H; Okishio K; Okada M; Yoshino I; Okami J; Takahashi K; Ikeda N; Tanahashi M; Tambo Y; Saito H; Toyooka S; Inokawa H; Chen-Yoshikawa T; Yokoyama T; Okamoto T; Yanagitani N; Oki M; Takahama M; Sawa K; Tada H; Nakagawa K; Mitsudomi T; Nishio K
Mol Oncol; 2024 Feb; 18(2):305-316. PubMed ID: 37864465
[TBL] [Abstract] [Full Text] [Related]
5. [Impact of immunotherapy on the therapeutic strategy for the management of stage I non-small cell lung cancer: The radiation oncologist's point of view].
Khalifa J
Cancer Radiother; 2023 Sep; 27(6-7):653-658. PubMed ID: 37573193
[TBL] [Abstract] [Full Text] [Related]
6. Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell lung cancer, ETCTN 10399.
Gentzler RD; Villaruz LC; Rhee JC; Horton B; Mock J; Hanley M; Kim K; Rudek MA; Phelps MA; Carducci MA; Piekarz R; Park KS; Bullock TN; Rudin CM
Oncologist; 2023 Nov; 28(11):1007-e1107. PubMed ID: 37555284
[TBL] [Abstract] [Full Text] [Related]
7. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
[TBL] [Abstract] [Full Text] [Related]
8. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
Tan S; Chao R
Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
[TBL] [Abstract] [Full Text] [Related]
9. Postoperative pulmonary complications in older patients undergoing elective surgery with a supraglottic airway device or tracheal intubation.
Yang LQ; Zhu L; Shi X; Miao CH; Yuan HB; Liu ZQ; Gu WD; Liu F; Hu XX; Shi DP; Duan HW; Wang CY; Weng H; Huang ZL; Li LZ; He ZZ; Li J; Hu YP; Lin L; Pan ST; Xu SH; Tang D; Sessler DI; Liu J; Irwin MG; Yu WF;
Anaesthesia; 2023 Aug; 78(8):953-962. PubMed ID: 37270923
[TBL] [Abstract] [Full Text] [Related]
10. LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity.
Cui J; Wang Y; Tian X; Miao Y; Ma L; Zhang C; Xu X; Wang J; Fang W; Zhang X
Antioxid Redox Signal; 2023 Sep; 39(7-9):491-511. PubMed ID: 37166352
[No Abstract] [Full Text] [Related]
11. Acetylation regulates the nucleocytoplasmic distribution and oncogenic function of karyopherin alpha 2 in lung adenocarcinoma.
Feng HP; Liu YC; Wang CL; Liao WC; Yu JS; Yu CJ
Biochem Biophys Res Commun; 2023 Jun; 659():96-104. PubMed ID: 37060831
[TBL] [Abstract] [Full Text] [Related]
12. Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay.
Danziger N; Sokol ES; Graf RP; Hiemenz MC; Maule J; Parimi V; Palmieri C; Pusztai L; Ross JS; Huang RSP
Oncologist; 2023 Apr; 28(4):319-326. PubMed ID: 36866462
[TBL] [Abstract] [Full Text] [Related]
13. Integrative radiomics and transcriptomics analyses reveal subtype characterization of non-small cell lung cancer.
Lin P; Lin YQ; Gao RZ; Wan WJ; He Y; Yang H
Eur Radiol; 2023 Sep; 33(9):6414-6425. PubMed ID: 36826501
[TBL] [Abstract] [Full Text] [Related]
14. Competence remodels the pneumococcal cell wall exposing key surface virulence factors that mediate increased host adherence.
Minhas V; Domenech A; Synefiaridou D; Straume D; Brendel M; Cebrero G; Liu X; Costa C; Baldry M; Sirard JC; Perez C; Gisch N; Hammerschmidt S; Håvarstein LS; Veening JW
PLoS Biol; 2023 Jan; 21(1):e3001990. PubMed ID: 36716340
[TBL] [Abstract] [Full Text] [Related]
15. STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.
Zhang X; Chen Q; He Y; Shi Q; Yin C; Xie Y; Yu H; Bao Y; Wang X; Tang C; Dong Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):19. PubMed ID: 36639675
[TBL] [Abstract] [Full Text] [Related]
16. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
Xu F; Cui WQ; Liu C; Feng F; Liu R; Zhang J; Sun CG
FEBS Open Bio; 2023 Jan; 13(1):72-88. PubMed ID: 36282125
[TBL] [Abstract] [Full Text] [Related]
18. Long-term outcomes and risk factors of residual thoracic spaces after pleurectomy/decortication for mesothelioma.
Nakamura A; Hashimoto M; Kondo N; Matsumoto S; Nakamichi T; Kuribayashi K; Kijima T; Kodama H; Yamakado K; Hasegawa S
Eur J Cardiothorac Surg; 2022 Dec; 63(1):. PubMed ID: 36259940
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacological targeting of cbp/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells.
Ansari MSZ; Stagni V; Iuzzolino A; Rotili D; Mai A; Del Bufalo D; Lavia P; Degrassi F; Trisciuoglio D
Cancer Gene Ther; 2023 Jan; 30(1):124-136. PubMed ID: 36117234
[TBL] [Abstract] [Full Text] [Related]
20. Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway.
Zhang T; Xia W; Song X; Mao Q; Huang X; Chen B; Liang Y; Wang H; Chen Y; Yu X; Zhang Z; Yang W; Xu L; Dong G; Jiang F
J Hematol Oncol; 2022 Aug; 15(1):114. PubMed ID: 35982471
[TBL] [Abstract] [Full Text] [Related]
[Next]
